Prevalence of systemic sclerosis in Valtrompia in northern Italy. A collaborative study of rheumatologists and general practitioners

Clinical and Experimental Rheumatology

Volumn 25, Issue 6, 2007, Pages 878-880

  Airò, Paolo ^a   Tabaglio, Erminio ^a   Frassi, Micol ^a   Scarsi, Mirko ^a   Danieli, Elisabetta ^a   Rossi, Mara ^b  

^a Spedali Civili ^*  (Italy)

^b Department of Systemic Autoimmune Diseases   (Italy)

Author keywords

Italy; Prevalence; Systemic sclerosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENERAL PRACTITIONER; HUMAN; ITALY; MALE; MEDICAL RECORD REVIEW; MEDICAL SPECIALIST; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

AGED; AGED, 80 AND OVER; FAMILY PRACTICE; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PREVALENCE; RHEUMATOLOGY; SCLERODERMA, SYSTEMIC;

EID: 38649114112     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. CIMMINO MA, HAZES JM: Introduction: Value of epidemiological research for clinical practice. Best Pract Res Clin Rheumatol 2002; 16: vii-xii.
2. MAYES MD, LACEY JV JR, BEEBE-DIMMER J et al.: Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55.
3. GEIRSSON AJ, STEINSSON K, GUTHMUNDSSON S, SIGURTHSSON V: Systemic sclerosis in Iceland. A nationwide epidemiological study. Ann Rheum Dis 1994; 53: 502-5.
4. ALLCOCK RJ, FORREST I, CORRIS PA, CROOK PR, GRIFFITHS ID: A study of the prevalence of systemic sclerosis in northeast England. Rheumatology (Oxford) 2004; 43: 596-602.
5. LE GUERN V, MAHR A, MOUTHON L, JEANNERET D, CARZON M, GUILLEVIN L: Prevalence of systemic sclerosis in a French multiethnic county. Rheumatology (Oxford) 2004; 43: 1129-37.
6. ALAMANOS Y, TSIFETAKI N, VOULGARI PV et al.: Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002. Semin Arthritis Rheum 2005; 34: 714-20
7. VALENTINI G, BLACK CM: Systemic Sclerosis. Best Pract Res Clin Rheumatol 2002; 16: 807-16.
8. MAYES MD: Scleroderma epidemiology. Rheum Dis Clin N Am 2003; 29: 239-54.
9. WITTEL JT, COLTON T, SIDEL VW: Capture-recapture methods for assessing the completeness of case ascertainment when using multiple information sources. J Chron Dis 1974; 27: 25-36.
10. VALENTINI G, MEDSGER TA JR, SILMAN AJ, BOMBARDIERI S: The assessment of the patient with systemic sclerosis. Clin Exp Rheumatol 2003; (Suppl. 29): S1-S56.
11. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE AMERICAN RHEUMATISM ASSOCIATION DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE. Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum 1980; 23: 581-90.
12. LEROY EC, MEDSGER TA JR: Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-6.
13. SCUSSEL-LONZETTI L, JOYAL F, RAYNAULD JP et al.: Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: Addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001; 44: 735-6.
14. VALTER I, SARETOK S, MARICQ HR: Prevalence of scleroderma-spectrum disorders in the general poulation of Estonia. Scand J Rheumatol 1997; 26: 419-25.
15. CZIRJAK L, KISS CG, LOVEI C et al.: Survey of Raynaud's phenomenon and systemic sclerosis based on a representative study of 10,000 south-Transdanubian Hungarian inhabitants. Clin Exp Rheumatol 2005; 23: 801-8.